logo

For the Inventor, By the Inventor

Amsterdam, Netherlands

Petrus Johannes Lenting

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Stichting Sanquin Bloedvoorziening, Stiching Centraal Laboratorium Van De Bloedtransfusiedienst Van Nederlandse Rode Kruis. Active years: 2001-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petrus Johannes Lenting. Retrieved from https://idiyas.com/inventor/petrus-johannes-lenting

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:

goldMedal3 out of 28 
 
Stichting Sanquin Bloedvoorziening
 patents
silverMedal1 out of 1 
 
Stiching Centraal Laboratorium Van De Bloedtransfusiedienst Van Nederlandse Rode Kruis
 patent

Years Active: 2001-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 8546332 - Factor VIII polypeptide having factor VIII:C activity (2013-10-01),
2. 7544660 - Factor VIII polypeptide having factor VIII:C activity (2009-06-09),
3. 6919311 - Factor VII polypeptide having factor VII:C activity (2005-07-19),
4. 6284871 - Factor IX binding peptides, derived from factor VIII and their use as inhibitors of blood coagulation (2001-09-04),

Title: The Innovations of Petrus Johannes Lenting

Introduction

Petrus Johannes Lenting is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII polypeptides. With a total of 4 patents to his name, Lenting's work has had a profound impact on medical science.

Latest Patents

Lenting's latest patents focus on Factor VIII polypeptides that exhibit FVIII:C activity. These polypeptides contain modifications in the A3, C1, and C2 domains of the light chain of Factor VIII. They are characterized by their binding affinity to low-density lipoprotein receptor protein, along with methods for producing these innovative polypeptides.

Career Highlights

Throughout his career, Lenting has worked with prominent organizations such as Stichting Sanquin Bloedvoorziening and Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Nederlandse Rode Kruis. His work in these institutions has allowed him to advance research in blood transfusion and related fields.

Collaborations

Lenting has collaborated with esteemed colleagues, including Koenraad Mertens and Jan Aart Van Mourik. These partnerships have further enriched his research and development efforts.

Conclusion

Petrus Johannes Lenting's contributions to biotechnology, particularly in the area of Factor VIII polypeptides, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the field and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…